ea0056oc10.4 | Cardiovascular aspects of endocrine diseases | ECE2018
Jimenez Ines
, Crespo Irene
, Cuesta Martin
, Elvira Carlos
, de Miguel Paz
, Santiago Alejandro
, Fernandez Luzdivina
, de Parayuelo Maria Victoria Saez
, Calle Alfonso
, Runkle Isabelle
Introduction: Control of hypertension (HT) is essential to reduce cardiovascular events in diabetic patients (DPts). However, studies indicate that only 50% of DPts with treated hypertension present adequate blood pressure (BP) control. Yet Endocrine-Society-Guideline (ESG) screening for primary hyperaldosteronism (PHA) is rarely applied. Furthermore, in patients with essential hypertension (EH), longer-acting hypertension medication (HM) improves 24-hour BP when compared to r...